Michalis Georgiou1,2, Naser Ali2, Elizabeth Yang2, Parampal S Grewal2, Tryfon Rotsos3, Nikolas Pontikos1,2, Anthony G Robson1,2, Michel Michaelides4,5. 1. UCL Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK. 2. Moorfields Eye Hospital, London, UK. 3. First Division of Ophthalmology, General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece. 4. UCL Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK. michel.michaelides@ucl.ac.uk. 5. Moorfields Eye Hospital, London, UK. michel.michaelides@ucl.ac.uk.
Abstract
PURPOSE: To present the detailed retinal phenotype of patients with Leber Congenital Amaurosis/Early-Onset Severe Retinal Dystrophy (LCA/EOSRD) caused by sequence variants in four genes, either not (n = 1) or very rarely (n = 3) previously associated with the disease. METHODS: Retrospective case series of LCA/EOSRD from four pedigrees. Chart review of clinical notes, multimodal retinal imaging, electrophysiology, and molecular genetic testing at a single tertiary referral center (Moorfields Eye Hospital, London, UK). RESULTS: The mean age of presentation was 3 months of age, with disease onset in the first year of life in all cases. Molecular genetic testing revealed the following disease-causing variants: PRPF8 (heterozygous c.5804G > A), PRPH2 (homozygous c.620_627delinsTA, novel variant), RP1 (homozygous c.4147_4151delGGATT, novel variant) and RPGR (heterozygous c.1894_1897delGACA). PRPF8, PRPH2, and RP1 variants have very rarely been reported, either as unique cases or case reports, with limited clinical data presented. RPGR variants have not previously been associated with LCA/EOSRD. Clinical history and detailed retinal imaging are presented. CONCLUSIONS: The reported cases extend the phenotypic spectrum of PRPF8-, PRPH2-, RP1-, and RPGR-associated disease, and the genotypic spectrum of LCA/EOSRD. The study highlights the importance of retinal and functional phenotyping, and the importance of specific genetic diagnosis to potential future therapy.
PURPOSE: To present the detailed retinal phenotype of patients with Leber Congenital Amaurosis/Early-Onset Severe Retinal Dystrophy (LCA/EOSRD) caused by sequence variants in four genes, either not (n = 1) or very rarely (n = 3) previously associated with the disease. METHODS: Retrospective case series of LCA/EOSRD from four pedigrees. Chart review of clinical notes, multimodal retinal imaging, electrophysiology, and molecular genetic testing at a single tertiary referral center (Moorfields Eye Hospital, London, UK). RESULTS: The mean age of presentation was 3 months of age, with disease onset in the first year of life in all cases. Molecular genetic testing revealed the following disease-causing variants: PRPF8 (heterozygous c.5804G > A), PRPH2 (homozygous c.620_627delinsTA, novel variant), RP1 (homozygous c.4147_4151delGGATT, novel variant) and RPGR (heterozygous c.1894_1897delGACA). PRPF8, PRPH2, and RP1 variants have very rarely been reported, either as unique cases or case reports, with limited clinical data presented. RPGR variants have not previously been associated with LCA/EOSRD. Clinical history and detailed retinal imaging are presented. CONCLUSIONS: The reported cases extend the phenotypic spectrum of PRPF8-, PRPH2-, RP1-, and RPGR-associated disease, and the genotypic spectrum of LCA/EOSRD. The study highlights the importance of retinal and functional phenotyping, and the importance of specific genetic diagnosis to potential future therapy.
Entities:
Keywords:
Childhood blindness; EOSRD; Early onset retinal dystrophy; Inherited retinal dystrophy; LCA; Leber congenital amaurosis; PRPF8; PRPH2; RP1; RPGR; SECORD; Severe early childhood onset retinal dystrophy
Authors: J Ma; J C Norton; A C Allen; J B Burns; K W Hasel; J L Burns; J G Sutcliffe; G H Travis Journal: Genomics Date: 1995-07-20 Impact factor: 5.736
Authors: James W B Bainbridge; Manjit S Mehat; Venki Sundaram; Scott J Robbie; Susie E Barker; Caterina Ripamonti; Anastasios Georgiadis; Freya M Mowat; Stuart G Beattie; Peter J Gardner; Kecia L Feathers; Vy A Luong; Suzanne Yzer; Kamaljit Balaggan; Ananth Viswanathan; Thomy J L de Ravel; Ingele Casteels; Graham E Holder; Nick Tyler; Fred W Fitzke; Richard G Weleber; Marko Nardini; Anthony T Moore; Debra A Thompson; Simon M Petersen-Jones; Michel Michaelides; L Ingeborgh van den Born; Andrew Stockman; Alexander J Smith; Gary Rubin; Robin R Ali Journal: N Engl J Med Date: 2015-05-04 Impact factor: 91.245
Authors: Firoz Kabir; Inayat Ullah; Shahbaz Ali; Alexander D H Gottsch; Muhammad Asif Naeem; Muhammad Zaman Assir; Shaheen N Khan; Javed Akram; Sheikh Riazuddin; Radha Ayyagari; J Fielding Hejtmancik; S Amer Riazuddin Journal: Mol Vis Date: 2016-06-10 Impact factor: 2.367
Authors: Neruban Kumaran; Michalis Georgiou; James W B Bainbridge; Mette Bertelsen; Michael Larsen; Fiona Blanco-Kelly; Carmen Ayuso; Hoai Viet Tran; Francis L Munier; Angelos Kalitzeos; Michel Michaelides Journal: Invest Ophthalmol Vis Sci Date: 2020-04-09 Impact factor: 4.799
Authors: Evgenia Anikina; Michalis Georgiou; James Tee; Andrew R Webster; Richard G Weleber; Michel Michaelides Journal: Am J Ophthalmol Date: 2021-07-22 Impact factor: 5.258